| 35.71 Data as of Jun 18 |  +0.30 / +0.85%Today’s Change | 18.48 Today|||52-Week Range 42.41 | +60.57% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Glaxosmithkline Plc |  Buy | 8/03/2012 | 316,334 | $28.21 | $8.9M | +29.20% |
Winningham Rick E Chief Executive Officer |  Sale | 4/30/2013 | 253,955 | $33.64 | $8.5M | +5.81% |
Glaxosmithkline Plc | Buy | 11/02/2012 | 280,348 | $22.51 | $6.3M | +69.81% |
Aguiar Michael W Chief Financial Officer & Senior Vice President | Sale | 4/30/2013 | 160,779 | $33.77 | $5.4M | +5.81% |
Glaxosmithkline Plc | Buy | 4/30/2013 | 193,563 | $23.62 | $4.6M | +5.81% |
Winningham Rick E Chief Executive Officer | Buy | 4/30/2013 | 385,161 | $9.69 | $3.7M | +5.81% |
Brinkley David L Head of Business Development | Sale | 8/03/2012 | 123,917 | $27.92 | $3.5M | +29.20% |
Aguiar Michael W Chief Financial Officer & Senior Vice President | Buy | 4/30/2013 | 170,879 | $17.91 | $3.1M | +5.81% |
Glaxosmithkline Plc | Buy | 2/15/2013 | 116,527 | $22.13 | $2.6M | +61.36% |
Aguiar Michael W Chief Financial Officer & Senior Vice President | Sale | 8/07/2012 | 60,000 | $27.04 | $1.6M | +31.92% |
.
